Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Mirum Pharmaceuticals, Inc. (MIRM)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 53,602,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Mirum Pharmaceuticals is a biopharmaceutical company focused on the identification, acquisition, development and commercialization of therapies for rare and orphan diseases. Co.'s focus is the development and commercialization of LIVMARLI® (maralixibat) oral solution (Livmarli) and volixibat. Livmarli is an oral solution approved as a once daily medicine for cholestatic pruritus in patients with Alagille syndrome one year of age and older. Co.'s second product candidate, volixibat, an oral, minimally-absorbed agent designed to inhibit ileal bile acid transporter, for the treatment of adult patients with cholestatic liver diseases.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 4,000 4,000 175,963 175,963
Total Buy Value $101,200 $101,200 $4,703,025 $4,703,025
Total People Bought 1 1 2 2
Total Buy Transactions 2 2 8 8
Total Shares Sold 4,303 26,974 69,916 431,922
Total Sell Value $111,017 $737,972 $1,983,116 $9,495,201
Total People Sold 1 5 6 8
Total Sell Transactions 1 12 21 30
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 191
  Page 6 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Clements Ian Chief Financial Officer   •       –      –    2020-12-23 4/A B $18.65 $29,691 D/D 1,592 7,871 2.74     -
   Peetz Christopher President and CEO   •       •      –    2020-12-23 4 B $18.60 $93,480 I/I 5,000 201,570 2.66     -
   Clements Ian Chief Financial Officer   •       –      –    2020-12-23 4 B $18.55 $45,975 D/D 2,470 7,841 2.74     -
   Longpre Lara Chief Development Officer   •       –      –    2020-11-10 4 A $15.27 $12,549 D/D 822 75,822     -
   Radovich Peter Chief Operating Officer   •       –      –    2020-11-10 4 A $15.27 $13,144 D/D 861 3,506     -
   Tucker Edwin Jonathan Chief Medical Officer   •       –      –    2020-11-10 4 A $15.27 $19,464 D/D 1,275 32,275     -
   Clements Ian Chief Financial Officer   •       –      –    2020-11-10 4 A $15.27 $20,930 D/D 1,371 5,371     -
   Vig Pamela Chief Scientific Officer   •       –      –    2020-11-10 4 A $15.27 $9,083 D/D 595 2,207     -
   Peetz Christopher President and CEO   •       •      –    2020-11-10 4 A $15.27 $20,930 D/D 1,371 1,371     -
   Tucker Edwin Jonathan Chief Medical Officer   •       –      –    2020-10-30 4 OE $7.70 $192,500 D/D 25,000 31,000     -
   Radovich Peter Chief Operating OfficerOfficer   •       –      –    2020-04-28 3 IO $0.00 $0 D/D 0 2,645     -
   Tucker Edwin Jonathan Chief Medical Officer   •       –      –    2020-03-20 4 B $11.90 $29,740 D/D 2,500 6,000 2.74     -
   Tucker Edwin Jonathan Chief Medical Officer   •       –      –    2020-03-19 4 B $9.91 $19,818 D/D 2,000 3,500 2.74     -
   Tucker Edwin Jonathan Chief Medical OfficerOfficer   •       –      –    2019-10-24 3 IO $0.00 $0 D/D 0 1,500     -
   Fischer Laurent Director   –       •      –    2019-09-17 4 B $9.37 $15,435 D/D 1,648 6,750 2.39     -
   Fischer Laurent Director   –       •      –    2019-09-16 4 B $9.47 $4,280 D/D 452 5,102 2.31     -
   Longpre Lara CHIEF DEVELOPMENT OFFICER   •       –      –    2019-09-10 4 B $10.64 $10,268 D/D 965 105,372 0.01     -
   Brege Laura Director   –       •      –    2019-09-10 4 B $11.22 $112,200 D/D 10,000 10,000 2.39     -
   Fischer Laurent Director   –       •      –    2019-09-10 4 B $10.29 $9,881 D/D 960 4,650 2.39     -
   Fischer Laurent Director   –       •      –    2019-09-09 4 B $10.54 $20,992 D/D 1,970 3,690 2.39     -
   Peetz Christopher President and CEO   •       •      –    2019-09-09 4 B $10.90 $48,132 I/I 4,320 196,570 2.66     -
   Vig Pamela Chief Scientific Officer   •       –      –    2019-09-06 4 B $10.96 $17,682 D/D 1,612 1,612 2.74     -
   Fischer Laurent Director   –       •      –    2019-09-06 4 B $10.71 $18,429 D/D 1,720 1,720 2.39     -
   Clements Ian SVP Finance & Communications   •       –      –    2019-09-06 4 B $11.07 $46,039 D/D 4,000 4,000 2.74     -
   Peetz Christopher President and CEO   •       •      –    2019-09-06 4 B $10.91 $51,806 I/I 4,750 192,250 2.66     -
  191 Records found
  1  2  3  4  5  6  7  8   
  Page 6 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us